This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Medizinische Hochschule Hannover, Technische Universitát Dresden, Twincore, Zentrum Fur Experimentelle Und Klinische Infektionsforschung Gmbh. Active years: 2024.
Company Filing History:
1 out of 87 
1 out of 100 
1 out of 3 Years Active: 2024
Title: Lars Kaderali: Innovator in Respiratory Virus Diagnostics
Introduction
Lars Kaderali is a prominent inventor based in Greifswald, Germany. He has made significant contributions to the field of infectious disease diagnostics, particularly focusing on respiratory syncytial virus (RSV). His innovative work aims to improve patient outcomes through advanced genetic analysis.
Latest Patents
Kaderali holds a patent for a method that identifies genetic variants associated with the severity of infectious diseases. This invention specifically addresses the genetic factors linked to human respiratory syncytial virus (HRSV) infections, especially in infants. The patent outlines a diagnostic approach that utilizes identified genetic polymorphisms to enhance patient stratification and therapeutic decision-making, ultimately aiming to reduce fatal outcomes during infections.
Career Highlights
Throughout his career, Lars Kaderali has worked with esteemed institutions such as the Medical University of Hanover and Twincore, Center for Experimental and Clinical Infection Research. His expertise in the field has positioned him as a key figure in the development of innovative diagnostic methods for infectious diseases.
Collaborations
Kaderali has collaborated with notable professionals in his field, including Daniel Todt and Sibylle Haid. These partnerships have further enriched his research and contributed to advancements in the understanding of respiratory viruses.
Conclusion
Lars Kaderali's work in the realm of diagnostics for respiratory syncytial virus exemplifies the impact of innovative thinking in medicine. His contributions are vital for improving patient care and advancing the field of infectious disease research.